| Financial Year |
March 31 2023 |
| Monetary Funds |
4,725,039,108.26 |
| Held-for-trading Financial Assets |
111,571,984.10 |
| Notes Receivable |
-- |
| Accounts Receivable |
247,234,953.73 |
| Advances to Suppliers |
222,822,191.90 |
| Other Receivables |
4,375,493,715.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
7,146,468,484.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
177,514,403.33 |
| Other Current Assets |
199,292,622.70 |
| Total Current Assets |
17,205,437,463.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
6,165,312.50 |
| Long-term Equity Investment |
17,350,099,348.24 |
| Investment Properties |
5,296,616,837.26 |
| Fixed Assetes |
959,122,460.21 |
| Under-construction Projects |
10,508,457.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
237,970,921.34 |
| R&D expenses |
-- |
| Goodwill |
294,329,091.25 |
| Long-Term Deferred and Prepaid Expenses |
17,105,069.70 |
| Deferred Income Tax Assets |
54,325,526.11 |
| Other Non-Current Assets |
54,784,815.58 |
| Sub-Total of Non-Current Assets |
24,427,848,761.61 |
| Total Assets |
41,633,286,225.13 |
| Short-Term Loans |
9,769,237,440.69 |
| Trading Financial liabilities |
129,670.00 |
| Notes Payable |
60,000,000.00 |
| Accounts Payable |
389,811,190.82 |
| Accounts Received In Advance |
19,586,228.74 |
| Employee Compensation Payable |
8,171,154.82 |
| Taxes Payable |
52,839,572.31 |
| Interest Payable |
-- |
| Dividend Payable |
3,159,982.50 |
| Other payables |
1,890,980,614.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,466,197,324.08 |
| Other Current Liabilities |
129,056,210.22 |
| Sub-Total of Current Liabilities |
18,089,424,683.97 |
| Long-term Loans |
2,437,561,533.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,177,027,563.15 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
306,853,870.31 |
| Other Non-Current Liabilities |
281,804,801.78 |
| Sub-Total of Non-Current Liabilities |
5,225,761,356.03 |
| Total Liabilities |
23,315,186,040.00 |
| Paid-In Capital(Or Share Stock) |
3,658,744,935.00 |
| Capital Surplus |
8,568,191,728.18 |
| Surplus Reserve |
3,550,140,022.93 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,548,123,323.92 |
| Minority Stockholder's Interest |
-97,744,476.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
18,415,844,662.06 |
| Owner's Equity（Stockholder's Equity） |
18,318,100,185.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
41,633,286,225.13 |
